MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Validation of the Japanese version of the King’s Parkinson’s Disease Pain Scale and the King’s Parkinson’s Disease Pain Questionnaire

    K. Kurihara, S. Zfujioka, T. Mishima, Y. Tsuboi (Fukuoka, Japan)

    Objective: The purpose of this study is a validation of the Japanese version of the King's Parkinson's Disease Pain Scale (KPPS) and the King's Parkinson's…
  • 2023 International Congress

    Building and evaluating a speech biomarker from 2-seconds sustained phonation to detect and monitor Parkinson’s disease

    J. Tröger, L. Schwed, E. Baykara, N. Linz, J. Orozco-Arroyave (Saarbrücken, Germany)

    Objective: The aim of this work was to evaluate the feasibility of a speech-based algorithm geared towards frequent remote measuring of Parkinson’s disease severity with…
  • 2023 International Congress

    Dopamine dysregulation syndrome in Parkinson’s disease controlled by safinamine

    SK. Song, JH. Kang (Jeju-Si, Republic of Korea)

    Objective: To describe a case of dopamine dysregulation syndrome managed by safinamide. Background: Dopamine dysregulation syndrome (DDS) is an uncommon non-motor symptom of Parkinson disease…
  • 2023 International Congress

    Nocturnal behavior of people with Parkinson’s disease

    C. Duval, A. Karelis, J. Daneault (Montreal, Canada)

    Objective: Compare the nocturnal energy expenditure (kcal) and activity behavior of people with PD using a real-time wearable sensor, and determine whether these outcomes differed…
  • 2023 International Congress

    Safety in Levodopa/carbidopa Intestinal Gel (LCGI) titration in the Intensive Care Unit (ICU) setting for Parkinson’s Disease (PD) patient with severe dysphagia

    N. Lopez Ariztegui, G. Tabar Comellas, MI. Morales Casado, D. Rivero Rodriguez, M. Ennazeh, P. Leal Sanz (Toledo, Spain)

    Objective: Describe a PD patient with obsessive-compulsive disorder (OCD) and paranoid symptoms in whom treatment with LCIG was started in the ICU due to severe…
  • 2023 International Congress

    Enrollment phase sensing data from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) clinical trial

    T. Herrington, B. Beudel, J. Ostrem, L. Almeida, A. Ramirez-Zamora, A. Fasano, T. Hassell, K. Mitchell, E. Moro, M. Gostkowski, N. Sarangmat, S. Stanslaski, L. Tonder, Y. Tan, R. Summers, A. Singer, N. Morelli, R. Raike, H. Bronte-Stewart (Boston, USA)

    Objective: To describe enrollment sensing data from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson’s Disease (ADAPT-PD) trial (NCT04547712). Background: Local field potential (LFP)…
  • 2023 International Congress

    Validity and Reliability of the Turkish Version of the Radboud Oral Motor Inventory for Parkinson’s Disease (ROMP)

    M. Sapmaz Atalar, G. Genç, D. Selçuk Demi̇relli̇ (Kadıköy, Turkey)

    Objective: The aim of this study is to evaluate the validity and reliability of the Turkish version of ROMP for use in clinical settings. Background:…
  • 2023 International Congress

    Dopamine-responsive x-linked parkinsonism-epilepsy due to phosphoglycerate kinase-1 deficiency

    J. Parmera, T. Guimarães, R. Cury, F. Freua, E. Barbosa, F. Kok (São Paulo, Brazil)

    Objective: To describe the phenotype of three siblings with early-onset parkinsonism and epilepsy due to an x-linked phosphoglycerate kinase 1 deficiency, expanding our understanding of…
  • 2023 International Congress

    Exploring the Effects of Spinal Cord Stimulation for Gait Disturbances in Parkinson’s Disease

    N. Vanegas-Arroyave, K. Kwei, M. Lee, C. Prakash, L. Branco, A. Tarakad, Y. Taneff, N. Ince, A. Viswanathan, B. Najafi (Houston, USA)

    Objective: We sought to investigate the effects of SCS in PD, using placebo stimulation, compared to either tonic or burst stimulation paradigms. Background: Gait disturbances…
  • 2023 International Congress

    Early cognitive decline in Parkinson’s disease is anticipated by enhanced frontal theta oscillations and minor hallucinations

    F. Bernasconi, J. Pagonabarraga, H. Bejr-Kasem, S. Martinez-Horta, J. Marín-Lahoz, A. Horta-Barba, J. Kulisevsky, O. Blanke (Geneva, Switzerland)

    Objective: Identify alterations associated with minor hallucinations (MH) and their role in cognitive decline in patients with Parkinson’s disease (PD) by merging electroencephalography (EEG) with…
  • « Previous Page
  • 1
  • …
  • 316
  • 317
  • 318
  • 319
  • 320
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley